BioLineRx
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $299 | $477 | $195 | $427 |
Gross Profit | 159 | 382 | 91 | 343 |
EBITDA | -3,555 | -2,250 | -1,904 | -554 |
EBIT | -3,634 | -2,338 | -1,968 | -673 |
Net Income | -3,077 | -2,580 | -1,393 | -977 |
Net Change In Cash | 299 | 477 | 195 | 427 |
Free Cash Flow | -3,255 | -2,286 | -3,254 | -2,106 |
Cash | 4,626 | 2,504 | 3,249 | 7,914 |
Basic Shares | 4,441 | 4,433 | 4,351 | 3,949 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,189 | $28,940 | $4,800 | $0 |
Gross Profit | 430 | 19,677 | 1,108 | -654 |
EBITDA | -224 | 3,918 | -57,086 | -22,139 |
EBIT | -751 | -147 | -58,470 | -22,793 |
Net Income | -1,184 | -9,221 | -60,614 | -24,951 |
Net Change In Cash | 1,189 | 28,940 | 4,800 | 0 |
Free Cash Flow | -8,163 | -43,927 | -22,905 | -26,556 |
Cash | 3,249 | 10,436 | 4,255 | 10,587 |
Basic Shares | 4,108 | 1,996 | 1,605 | 1,289 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.77 |
2026-03-31 | -$0.58 |
2025-12-31 | -$0.32 |
2025-09-30 | -$0.22 |